Mersana Therapeutics Inc (MRSN) is up 1.82% Friday In Premarket Trading

Mersana Therapeutics Inc (MRSN) is higher by Friday morning, with the stock gaining 1.82% in pre-market trading to 1.68. MRSN's short-term technical score of 50 indicates that the stock has traded as bullishly as over the last month than 50% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, MRSN ranks higher than 68% of stocks. Mersana Therapeutics Inc has risen 38.66% over the past month, closing at $1.42 on November 3. During this period of time, the stock fell as low as $1.20 and as high as $1.73. MRSN has an average analyst recommendation of Buy. The company has an average price target of $5.33.

MRSN has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on MRSN!

See Full MRSN Report

Mersana Therapeutics Inc has a Long-Term Technical rank of 41. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 59% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, MRSN ranks better than 126% of stocks.

Important Dates for Investors in MRSN:

-Mersana Therapeutics Inc is set to release earnings on 2024-02-05. Over the last 12 months, the company has reported EPS of $-1.77. -We do not have a set dividend date for Mersana Therapeutics Inc at this time. Click Here To Get The Full Report on Mersana Therapeutics Inc (MRSN)